Magnum Navigates Profit Dip Amidst Weight Loss Jab Buzz and Investor Scrutiny
Magnum Ice Cream Company, a titan in the frozen dessert aisle boasting beloved brands like Cornetto and Wall’s, has recently unveiled its annual financial results, revealing a downturn in profits. This news, coupled with modest sales growth forecasts, led to a nearly 14 per cent drop in the company’s share price, leaving some investors less than enthused.
However, the company’s chief executive, Peter Ter Kulve, remains unfazed by the potential impact of the burgeoning popularity of weight-loss injections on ice cream sales. He contends that while these medications, such as Ozempic, may curb “mindless munching” – a phenomenon he acknowledges as a positive development – the fundamental human desire for treats and indulgences persists.
These latest figures mark Magnum’s first financial report since its separation from the food conglomerate Unilever last year. The demerger, as it’s known, was cited as a primary reason for a significant 48.4 per cent fall in reported profits. Specifically, Magnum’s profits dipped to £267 million, while revenue held steady at £6.9 billion.
The ice cream giant projected sales growth in the range of 3 to 5 per cent for the upcoming period. This forecast, however, failed to ignite investor excitement, especially when contrasted with the 4.2 per cent growth achieved in the previous year.
The “Lipstick Effect” and the Future of Indulgences
Addressing analysts, CEO Ter Kulve painted a picture of a “healthy and resilient” ice cream market. He drew a parallel to the “lipstick effect,” an economic theory suggesting that consumers tend to purchase affordable luxury items, like a tube of lipstick, as a mood enhancer and a small indulgence during times of economic uncertainty and stress. He believes this phenomenon bodes well for the ice cream sector.
Furthermore, Ter Kulve suggested that the rise of weight-loss injectables presents an opportunity for Magnum to “further premiumise the category.” This strategic outlook hints at a focus on higher-value, perhaps more artisanal or health-conscious, offerings within their product portfolio.
In line with this strategy, Magnum has been actively expanding its range of “better for you” options. This includes the introduction of smaller, more portion-controlled versions of popular products, such as Magnum Bonbons and Ben & Jerry’s Peaces. This move caters to consumers seeking moderation without entirely sacrificing their favourite treats.
Looking ahead, Ter Kulve articulated the company’s commitment to its strategic roadmap. “Looking ahead, we are focused on executing our growth strategy and driving the productivity programme to deliver profitable growth,” he stated, underscoring a dual focus on expanding market reach and enhancing operational efficiency.
Ben & Jerry’s Co-Founder’s Renewed Criticism
Magnum’s financial disclosure coincides with renewed public commentary from Ben Cohen, the co-founder of the iconic Ben & Jerry’s brand, which is part of the Magnum portfolio. Cohen has once again voiced his disapproval of its current ownership, alleging that the company is actively suppressing the brand’s efforts to make political statements.
In an open letter addressed to Magnum investors, Cohen expressed his disappointment, stating, “I’m sorry to say that Unilever and Magnum are no longer the companies you were led to believe they were.” He went on to urge Magnum to divest the Ben & Jerry’s brand.
This is not the first time Cohen has aired these grievances. Last year, Magnum CEO Peter Ter Kulve responded to similar calls by stating, “Ben wants to have it back but I am sorry Ben, it is not for sale.” The agreement under which Ben & Jerry’s was acquired by Unilever for £251 million in 2000 stipulated that the brand would be managed by an independent board, a structure Cohen feels is no longer being respected.
Cohen has specifically accused Unilever and Magnum of attempting to block Ben & Jerry’s from expressing its support for Gaza and its criticism of Israel amidst the ongoing conflict in the Middle East. This controversy highlights a long-standing tension between the brand’s social mission and the business objectives of its parent company.
